Blue Jet Healthcare Limited — PPTs, 30-10-2024: Investor Presentation

Blue Jet Healthcare Limited announced its Q2 and H1 FY25 financial results, reporting a 27.8% QoQ revenue growth to ₹2,083 mn, coupled with a 54.4% increase in PAT to ₹583 mn. The company achieved improved profitability driven by a favorable product mix and growing sales of contrast media. It declared its first dividend payout of ₹1 per share, and commenced commercial dispatches from its new Ambernath facility, focusing on high-intensity sweeteners and pharma intermediates.